Moneycontrol
HomeNewsTrendsSportsPandemic shaves off IPL brand value by 3.6% to Rs 45,800 crore: Report
Trending Topics

Pandemic shaves off IPL brand value by 3.6% to Rs 45,800 crore: Report

In 2019, the IPL commanded a brand value of Rs 47,500 crore, which had grown 7 percent over the previous year.

March 10, 2021 / 17:23 IST
Story continues below Advertisement

Hit by the coronavirus pandemic, the Indian Premier League (IPL) lost 3.6 percent of its brand value to Rs 45,800 crore in 2020, says a brand valuation report.

In 2019, the IPL commanded a brand value of Rs 47,500 crore, which had grown 7 percent over the previous year.

Story continues below Advertisement

Though one of the key franchises, the Mumbai Indians — owned by the Reliance Group — has retained the top spot in the brand rankings for the fifth consecutive year at a brand value of Rs 761.0 crore, it is down 5.9 percent from 2019, Duff & Phelps said on Wednesday releasing the seventh edition of its valuation report on IPL.

Chennai Super Kings (CSK) and Kolkata Knight Riders (KKR) have seen their brand value erode by 16.5 percent and 13.7 percent, respectively, from 2019.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show